Follow us...

 

Search News Archives

Monthly Newsletter

 

Lab Bulletin August Newsletter

view the latest issue

Subscribe

News Channels

 

New Laboratory Products

 

Lab News

 

Microscopy & Image Analysis

 

Separation Science

 

Research & Case Studies

 

Literature

 

Videos

 

Events | Webinars

 

 

 

Conferences | Events

Georgia Tech Chooses TAP’s Micro Bioreactor for Novel Stem Cell Research To Determine Process Parameters for Affordable Stem Cell Manufacturing

ambr TAP BiosystemsTAP Biosystems, a leading supplier of innovative automation and consumables for life science applications today announced it is installing an advanced micro bioreactor system (ambrTM) system at The Georgia Institute of Technology, a leading US research university. 

The ambr system, which closely replicates the characteristics of bioreactors at micro scale, will be used by scientists in Georgia Tech's new Stem Cell Engineering Center to determine optimal conditions for culturing mouse and human pluripotent stem  cell lines, which could be used in drug discovery and cell therapy applications. 

Additionally, the ambr system will be used over a five year programme to help train at least 30 NSF (National Science Foundation) funded IGERT (Integrated Graduate Education Research Training) trainees in stem cell production. This will allow these researchers to understand how to scale and control stem cells into clinically relevant numbers and will develop the next generation of experts in stem cell biomanufacturing.

Dr Todd McDevitt, Director of the Stem Cell Engineering Center at The Georgia Institute of Technology said: "Manufacturing stem cells in bioreactors is a goal for cost-effective production and to date we have studied stem cell differentiation using rotary orbital suspension culture. This type of culture method is not as practical for bioprocess modelling as it is more time consuming and almost impossible to evaluate a wide range of media and culture conditions in parallel."

Dr McDevitt added: "Our research requires automation which offers a rigorous approach and we initially considered developing our own equipment until we heard about the ambr system. The ambr system is ideal for studying a large number of parameters that could affect stem cell growth and differentiation and we will use the ambr technology to predict stem cell performance in large scale bioreactors."

Dr Barney Zoro, ambr Product Manager at TAP Biosystems stated: "The cost of generating many types of stem cell at clinically relevant scale is currently prohibitive. Development of suspension culture processes will allow production of larger quantities of more affordable stem cells and we're pleased that this leading institute has chosen the ambr system to optimise these important stem cell bioreactor cultures. Through their research, the ambr system could be instrumental in helping to deliver cell lines for drug discovery assays, as well as enabling allogeneic cell therapies to become more readily available."

For more info visit www.tapbiosystems.com


If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners